logo
advertisement
   Login        
    Register        
   Search       
    Submit to CRTER
   Submit to NRR  
 
  Location:Home>>NRR>>Current Issue>>

Influence of ginsenoside on expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in the medial septum of aged rats★

Publisher:Quzwzb  Publish Time:Tuesday, November 25, 2008 
Source:Neural Regen Res,2008,3(5),490-3

Liang Zeng1, Haihua Zhao2, Yongli Lü2, Wenbo Dai3

1Department of Anatomy, Shenyang Medical College, Shenyang   110034, Liaoning Province, China

2Department of Anatomy, China Medical University, Shenyang   110001, Liaoning Province, China

3Department of Pathology, First People’s Hospital, Shenyang   110041, Liaoning Province, China

Liang Zeng★, Studying for master’s degree, Department of Anatomy, Shenyang Medical College, Shenyang 110034, Liaoning Province, China

Zeng L, Zhao HH, Lü YL, Dai WB. Influence of ginsenoside on expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in the medial septum of aged rats. Neural Regen Res 2008;3(5):490-3

 

Abstract

BACKGROUND: It has been shown that ginsenoside, the effective component of ginseng, can enhance expression of choline acetyl transferase, as well as brain-derived neurotrophic factor (BDNF) and its receptor tyrosine kinase B (TrkB), in cholinergic neurons of the basal forebrain.

OBJECTIVE: To qualitatively and quantitatively verify the influence of ginsenoside on expression of BDNF and its receptor, TrkB, in the medial septum of aged rats, and to provide a molecular basis for clinical application.

DESIGN, TIME AND SETTING: A contrast study, which was performed in the Department of Anatomy, China Medical University, and the Department of Anatomy, Shenyang Medical College between December 2005 and May 2007.

MATERIALS: Thirty-five, healthy, female, Sprague Dawley rats were selected for this study. Ginsenoside (81% purity) was provided by Jilin Ji’an Wantai Chinese Medicine Factory; anti-BDNF antibody, anti-TrkB antibody, and their kits were provided by Wuhan Boster Company.

METHODS: A total of 35 rats were divided into three groups: young (four months old), aging (26 months old), and ginsenoside. Rats in the ginsenoside group were administered ginsenoside (25 mg/kg/d) between 17 months and 26 months.

MAIN OUTCOME MEASURES: Immunohistochemistry and in situ hybridization were used to measure expression of BDNF and TrkB in the medial septum of aged rats, and the detected results were expressed as gray values.

RESULTS: ① Qualitative detection: using microscopy, degenerative neurons were visible in the medial septum in the aging group. However, neuronal morphology in the ginsenoside group was similar to neurons in the young group. ② Quantitative detection: the mean gray value of BDNF-positive and TrkB-positive products in the aging group were significantly higher than in the young group (t = 3.346, 4.169, P < 0.01); however, the mean gray value in the ginsenoside group was significantly lower than in the aging group (t = 2.432, 2.651, P < 0.01).

CONCLUSION: Ginsenoside can increase expression of BDNF and TrkB in the medial septum and delay the natural degeneration in aged rats.

Key words: BDNF; TrkB; ginsenoside; medial septum; aged rat

Full text:click

 

Print』『Close

      

All rights reserved    
Publishing House of Journal of Clinical Rehabilitation Tissue Engineering Research 
Publishing House of Neural Regeneration Research
CRTER website group Liao ICP 05011357

CRTER   Address:p.o.box  1200, shenyang  110004   Tel:024-23384352  Fax:024-23388105   Submission:
http://oa.crter.org/zglckfen/ch/index.aspx
NRR       Address:p.o.box  1234, shenyang  110004   Tel:024-23394178  Fax:024-23394178   Submission:
http://oa.crter.org/nrren/ch/index.aspx